...
okur-img

OnKure Therapeutics, Inc., Common Stock

OKUR

NMQ

$15.625

+$0.21

(1.36%)

1D

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$0
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
12.91K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$9.8 L
$77.6 H
$15.625

About OnKure Therapeutics, Inc., Common Stock

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado. more

Returns

Data is not properly formatted.

Financials

Dec '22Dec '23
Total Revenue--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses29.77M36.93M[{"date":"2022-12-31","value":80.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(29.77M)(36.93M)[{"date":"2022-12-31","value":-2976600000,"profit":false},{"date":"2023-12-31","value":-3693400000,"profit":false}]
Total Non-Operating Income/Expense--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(29.51M)(35.31M)[{"date":"2022-12-31","value":-2951200000,"profit":false},{"date":"2023-12-31","value":-3531100000,"profit":false}]
Income Taxes--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(29.51M)(35.31M)[{"date":"2022-12-31","value":-2951200000,"profit":false},{"date":"2023-12-31","value":-3531100000,"profit":false}]
Income From Discontinued Operations--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(29.51M)(35.31M)[{"date":"2022-12-31","value":-2951200000,"profit":false},{"date":"2023-12-31","value":-3531100000,"profit":false}]
EPS (Diluted)(21.23)(25.22)[{"date":"2022-12-31","value":-2122.7,"profit":false},{"date":"2023-12-31","value":-2522.36,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

OKUR
Current Ratio 1.83

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

OKUR
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

OKUR
Debt Ratio Lower is generally better. Negative is bad. 5.85
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -4.85

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

OKUR
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is OnKure Therapeutics, Inc. share price today?

OnKure Therapeutics, Inc. (OKUR) share price today is $15.625

Can Indians buy OnKure Therapeutics, Inc. shares?

Yes, Indians can buy shares of OnKure Therapeutics, Inc. (OKUR) on Vested. To buy OnKure Therapeutics, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OKUR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of OnKure Therapeutics, Inc. be purchased?

Yes, you can purchase fractional shares of OnKure Therapeutics, Inc. (OKUR) via the Vested app. You can start investing in OnKure Therapeutics, Inc. (OKUR) with a minimum investment of $1.

How to invest in OnKure Therapeutics, Inc. shares from India?

You can invest in shares of OnKure Therapeutics, Inc. (OKUR) via Vested in three simple steps:

  • Click on Sign Up or Invest in OKUR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in OnKure Therapeutics, Inc. shares
What is OnKure Therapeutics, Inc. 52-week high and low stock price?

The 52-week high price of OnKure Therapeutics, Inc. (OKUR) is $77.6. The 52-week low price of OnKure Therapeutics, Inc. (OKUR) is $9.8.

What is OnKure Therapeutics, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of OnKure Therapeutics, Inc. (OKUR) is

What is OnKure Therapeutics, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of OnKure Therapeutics, Inc. (OKUR) is 0.00

What is OnKure Therapeutics, Inc. dividend yield?

The dividend yield of OnKure Therapeutics, Inc. (OKUR) is 0.00%

What is the Market Cap of OnKure Therapeutics, Inc.?

The market capitalization of OnKure Therapeutics, Inc. (OKUR) is

What is OnKure Therapeutics, Inc.’s stock symbol?

The stock symbol (or ticker) of OnKure Therapeutics, Inc. is OKUR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top